| Literature DB >> 29765836 |
Anna R Patten1, Suk Yu Yau1, Christine J Fontaine1, Alicia Meconi1, Ryan C Wortman1, Brian R Christie1,2,3,4.
Abstract
In this review, the benefits of physical exercise on structural and functional plasticity in the hippocampus are discussed. The evidence is clear that voluntary exercise in rats and mice can lead to increases in hippocampal neurogenesis and enhanced synaptic plasticity which ultimately result in improved performance in hippocampal-dependent tasks. Furthermore, in models of neurological disorders, including fetal alcohol spectrum disorders, traumatic brain injury, stroke, and neurodegenerative disorders including Alzheimer's, Parkinson's and Huntington's disease exercise can also elicit beneficial effects on hippocampal function. Ultimately this review highlights the multiple benefits of exercise on hippocampal function in both the healthy and the diseased brain.Entities:
Keywords: Cornu Ammonis; Exercise; behaviour; dentate gyrus; hippocampus; neurogenesis; synaptic plasticity
Year: 2015 PMID: 29765836 PMCID: PMC5928528 DOI: 10.3233/BPL-150016
Source DB: PubMed Journal: Brain Plast ISSN: 2213-6304
Fig.1A simplified hippocampal circuitry illustrating trisynaptic and monosynaptic circuits. The basic circuitry of the hippocampus is commonly termed the trisynaptic circuit. Layer II of the entorhinal cortex provides input to the granule cells of the dentate gyrus via the medial (light blue) and lateral (purple) perforant paths. The dentate granule cells project to pyramidal cells of the CA3 via the mossy fibre pathway (green). CA3 pyramidal neurons project to the CA1 via schaffer collaterals (pink). The CA1 pyramidal cells project to both the subiculum and to layers V and VI of the entorhinal cortex. Abbreviations: Cornu Ammonis (CA); Dentate Gyrus (DG); Entorhinal Cortex (EC); Lateral Perforant Path (LPP); Medial Perforant Path (LPP); Mossy Fibres (MF); Schaffer Collaterals (SC); Subiculum (S).
Effect of voluntary running on hippocampal plasticity in healthy rodents
| Hippocampal neurogenesis | |||||
| Animal age | Species | Running period | Markers examined | Effect of running | Reference |
| 3 months old | Mouse | 12 days | BrdU | Increased cell | van Praag et al., |
| (Proliferation and | proliferation, | 1999 | |||
| Survival) | cell survival and | ||||
| NeuN | net neurogenesis | ||||
| (neurogenesis) | |||||
| 3 months old | Mouse | 30 days | BrdU (survival) | Increased cell | van Praag et al., |
| BrdU/NeuN | survival and | 1999 | |||
| (neuronal | neuronal | ||||
| differentiation) | differentiation | ||||
| 3 months old | Mouse | 45 days | BrdU (survival) | Increased cell | van Praag et al., 2005 |
| or 19 months old | survival and | ||||
| neuronal differentiation | |||||
| BrdU/NeuN/S100 | |||||
| triple labeling | |||||
| 6–8 weeks old | Mouse selectively | 40 days | BrdU (survival) | Increased cell | Rhodes et al., 2003 |
| bred for high | proliferation, | ||||
| levels of running | survival and | ||||
| BrdU/Neuro/ | neuronal | ||||
| S100 | differentiation | ||||
| labeling | |||||
| 6 weeks old | Mouse | 12 days or 19 days | BrdU (survival) | Increased cell | Synder et al., 2009 |
| PCNA (cell | proliferation | ||||
| proliferation) | after 14 days | ||||
| running, | |||||
| Increased cell | |||||
| survival in after | |||||
| both 14 days | |||||
| and 19 days of | |||||
| running | |||||
| 3 months old | Mouse | 12 days | BrdU(Proliferation | Increased cell | Brown et al., 2003 |
| and survival) | proliferation and | ||||
| survival | |||||
| 8-9 weeks old | Mouse | 14 days | BrdU, Ki67 (cell | Increased cell | Yau et al., 2014 |
| proliferation) | proliferation, | ||||
| DCX | neuronal | ||||
| (neurogenesis) | differentiation | ||||
| BrdU/DCX | and net | ||||
| (neuronal | neurogenesis | ||||
| differentiation) | |||||
| 8 weeks old | Mouse | 24 hours, 3 | BrdU, IdU, CldU | Increased cell | Brandt et al., 2010 |
| days, 7 days or | proliferation at | ||||
| 35 days | 24 hours, 3 days | ||||
| and 7 days | |||||
| (peak at 3 | |||||
| days). Return to | |||||
| baseline at 35 | |||||
| days | |||||
| 12 weeks old | Transgenic | 4 weeks | BrdU and nestin- | Specific | Kronenberg et al., 2003 |
| mouse | GFP positive cells | increase in type | |||
| expressing | 2b transient | ||||
| GFP driven by | amplifying | ||||
| nestin gene | progenitor cells | ||||
| promotor | |||||
| 74 days at end | Mouse | 3, 10 or 32 days | BrdU, Ki67, | Increased cell | Kronenberg et al., 2006 |
| of experiment | DCX, calretinin | proliferation at 3 | |||
| days and 10 | |||||
| days (peak at 3 | |||||
| days). Returned | |||||
| to baseline at 35 | |||||
| days. DCX and | |||||
| Calretinin | |||||
| increased at 10 | |||||
| days and 32 days. | |||||
| 2 months old | Mouse | 12 days | BrdU and PCNA | Increased cell | Kannangara et al., 2009 |
| (cell proliferation) | proliferation | ||||
| 6–8 weeks old | Rat | 7 days or 28 days | Brdu (cell | Increased cell | Yau et al., 2012 |
| proliferation) | proliferation and | ||||
| BrdU/DCX | differentiation | ||||
| (neuronal | following 28 | ||||
| differentiation) | days of running | ||||
| 6–8 weeks old | Rat | 14 days | BrdU (cell | Increased cell | Yau et al., 2011 |
| proliferation) | proliferation and | ||||
| BrdU/DCX co- | neuronal | ||||
| labeling (Neuronal | differentiation | ||||
| differentiation) | |||||
| 2 months old | Rat | 3, 7, 14, 28, 56 days | Ki 67 (cell | Increased cell | Patten et al., 2013 |
| proliferation) | proliferation | ||||
| NeuroD (neuronal | after 3,7 or 28 | ||||
| differentiation) | days of running | ||||
| Increased | |||||
| neuronal | |||||
| differentiation | |||||
| after 14 or 28 | |||||
| days of running |
Abbreviations: BrdU, bromodeoxyuridine; CA, Cornu Ammonis; DG, dentate gyrus; DCX, doublecortin; MWM, Morris Water Maze; PCNA, proliferating cell nuclear antigen.
Effects of voluntary running on adult hippocampal neurogenesis in animal models of neurological disorders
| Disease model | Animal age/ Model | Running period | Markers examined | Effect of running | Reference |
| FASD | 7 weeks old/ | 7 days | BrdU | Rescued deficit | Redila et al., 2006 |
| Rat | (proliferation | in proliferation | |||
| and survival) | and survival | ||||
| 4 weeks old/ | 12 days | BrdU | Increased | Helfer et al., 2009 | |
| Rat | (proliferation | proliferation, no | |||
| and survival) | effect on | ||||
| survival | |||||
| 7 weeks old/ | 12 days | Ki67, BrdU, | Increased | Boehme et al., 2011 | |
| Rat | NeuroD | proliferation | |||
| and neuronal | |||||
| differentiation | |||||
| 4 weeks old/ | 12 days (followed by | BrdU (survival) | Rescued deficit | Hamilton et al., 2014 | |
| Rat | 30 days enrichment) | in cell survival | |||
| TBI | Not reported | ||||
| Stroke | Adult/ Mouse/ | 42 days (beginning day | BrdU (Proliferaion) | Increased | Geibig et al., 2012 |
| of infarct) | proliferation | ||||
| photothrombotic | relative to | ||||
| cortical infarct | sedentary | ||||
| stroke group | |||||
| Adult/ Mouse/ | 42 days (beginning 7 | BrdU (Proliferation) | No change in | Chun et al., 2007 | |
| days after MCAO) | proliferation | ||||
| MCAO | |||||
| Adult/ Mouse/ | 42 days (beginning 7 | BrdU (Survival) | Increased | Chun et al., 2007 | |
| days after MCAO) | |||||
| MCAO | survival relative | ||||
| to sedentary | |||||
| stroke | |||||
| AD | 5 months old/ | 10 weeks | Nissl staining; | Prevented | Tapia-Rojas et al., 2015 |
| Mouse/ | BrdU (proliferation | neuronal loss; | |||
| APPswe/PS1 | and survival) | Increased | |||
| proliferation | |||||
| and neuronal | |||||
| differentiation | |||||
| 5 months old/ | 16 weeks | Nissl staining | Greater | Yuede et al., 2009 | |
| Mouse/ | hippocampal | ||||
| Tg2576 | volume | ||||
| 6 and 18 months | 10 days | BrdU, DCX, NeuN | Increased | Mirochnic et al., 2009 | |
| old / Mouse/ | proliferation | ||||
| APP23 | and neuronal | ||||
| differentiation | |||||
| in 18 month-old | |||||
| mice only | |||||
| PD | Not reported | ||||
| HD | 8–12 weeks old/ | 4 weeks | BrdU | No effect | Renoir et al., 2012 |
| Mouse/ | (proliferation | ||||
| R6/1 | and survival) | ||||
| 3 months old/ | 8 days | Ki67, BrdU, | No effect | Ransome and Hannan, 2013 | |
| Mouse/ | NeuN | ||||
| R6/1 |
Abbreviations: AD, Alzheimer’s Disease; BrdU, bromodeoxyuridine; DCX, doublecortin; FASD, fetal alcohol spectrum disorder; HD, Huntington’s Disease; MCAO, intraluminal middle cerebral artery occlusion; PD, Parkinson’s Disease; TBI, traumatic brain injury.
Effects of voluntary running on hippocampal synaptic plasticity in animal models of neurological disorders
| Animal model | Animal age | Running period | Area analyzed | Effect of running | Reference |
| FASD | 8 weeks old/ Rat | 10 days | DG | Rescued deficit in LTP | Christie et al., 2005 |
| TBI | Not reported | ||||
| Stroke | Not reported | ||||
| AD | 7 months old/ Mouse/ | ||||
| 3xTg-AD | 6 months | CA1 | Rescued deficit in LTP | García-Mesa et al., 2011 | |
| PD | Not reported | ||||
| HD | Not reported |
Abbreviations: AD, Alzheimer’s disease; CA, Cornu Ammonis; DG, dentate gyrus; FASD, fetal alcohol spectrum disorders; HD, Huntington’s disease; LTP, long-term potentiation; PD, Parkinson’s disease; TBI, traumatic brain injury.
Effects of voluntary running on hippocampal dependent behaviours in animal models of neurological disorders
| Animal model | Animal age/ Model | Running period | Behaviour examined | Effect of running | Reference |
| FASD | 8 weeks old/ | 10 days | MWM | Deficits in | Christie et al., 2005 |
| Rat | reference and | ||||
| working | |||||
| memory were | |||||
| reversed | |||||
| 3 weeks old/ | 30 days | MWM | Rescued | Thomas et al., 2008 | |
| Rat | deficits in | ||||
| reference | |||||
| memory | |||||
| 4 weeks old/ | 12 days | Contextual fear | No effect | Schreiber et al., 2012 | |
| Rat | (followed by | conditioning | |||
| 30 days | |||||
| enrichment) | |||||
| 4 weeks old/ | 12 days | Context pre- | Rescued | Hamilton et al., 2014 | |
| Rat | (followed by | exposure | deficits | ||
| 30 days | facilitation | ||||
| enrichment) | |||||
| TBI | Adult/ Rat/ | 7 days | MWM | Reduced | Grace et al., 2009 |
| Lateral FPI | (starting 14 | deficits in | |||
| days post | acquisition of | ||||
| injury) | spatial memory | ||||
| Adult/ Mouse/ | 4 weeks | MWM | Reduced | Piao et al., 2013 | |
| Left parietal | (starting 1 or | impairment in | |||
| CCI | 5 weeks post | acquisition of | |||
| injury) | spatial memory, | ||||
| reference | |||||
| memory, | |||||
| reversal | |||||
| memory | |||||
| acquisition, and | |||||
| reversal | |||||
| reference | |||||
| memory after 5 | |||||
| week delay in | |||||
| exercise onset | |||||
| No change after | |||||
| 1-week delay in | |||||
| exercise onset | |||||
| Adult/ Rat/ | 7 days | MWM | Increased | Griesbach et al., 2004 | |
| Lateral FPI | (starting day | impairment in | |||
| of injury) | acquisition of | ||||
| spatial memory | |||||
| Adult/ Rat/ | 7 days | MWM | Decreased | Griesbach et al., 2004 | |
| Lateral FPI | (starting 14 | impairment in | |||
| days post injury) | acquisition of | ||||
| spatial memory | |||||
| after delayed | |||||
| exercise | |||||
| initiation | |||||
| Stroke | Adult/ Mouse/ | 42 days | MWM | Increased rate | Geibig et al., 2012 |
| photothrombotic | (beginning | of spatial | |||
| cortical infarct | day of infarct) | memory | |||
| acquisition. No | |||||
| change in | |||||
| reference | |||||
| memory | |||||
| Adult/ Mouse/ MCAO | 42 days | MWM | Rescued | Chun et al., 2007 | |
| (beginning 7 | impairment in | ||||
| days after | acquisition of | ||||
| MCAO) | spatial memory | ||||
| AD | 5 months old/ | 16 weeks | Novel object recognition | Reduced | Yuede et al., 2009 |
| Mouse/ Tg2576 | decline in | ||||
| recognition | |||||
| memory | |||||
| 10–12 months | 6 weeks | Radial-arm water maze | Improved | Nichol et al., 2009 | |
| old/ Mouse/ | performance | ||||
| (less errors) | |||||
| 1 month old/ | 5 months | MWM | Enhanced | Adlard et al., 2005 | |
| Mouse/ | learning rate | ||||
| TgCRND8 | |||||
| 3 months old/ | 10 weeks | One-trial object | No effect | Richter et al., 2008 | |
| recognition paradigm, | |||||
| Barnes maze | |||||
| Mouse/ | |||||
| TgCRND8 | |||||
| 3 months old/ | 9 months | Two-trial Y-maze | Prevented | Belbarbi et al., 2011 | |
| Mouse/ | development of | ||||
| THY-Tau22 | memory | ||||
| alterations | |||||
| 4 and 7 months | 1 month and | MWM; Startle Response; | Rescued | García-Mesa et al., 2011 | |
| Dark and Light | |||||
| box test | |||||
| old/ Mouse/ | 6 months | retention | |||
| 3xTg-AD | deficiency; | ||||
| reduced BPSD- | |||||
| like behaviours | |||||
| 5 months old/ | 10 weeks | MWM | Prevented | Tapia-Rojas et al., 2015 | |
| Mouse/ | impairment in | ||||
| APPswe- | spatial acuity | ||||
| PS1 | and memory | ||||
| acquisition | |||||
| PD | Not reported | ||||
| HD | 10 weeks old/ | 10 weeks | T-maze; Y-maze | Rear-paw | Pang et al., 2006 |
| Mouse/ R6/1 | clasping onset | ||||
| delayed; | |||||
| rescued deficit | |||||
| in spatial | |||||
| working | |||||
| memory | |||||
| 8–12 weeks old/ | 4 weeks | Forced-swim test | Anti-depressive | Renoir et al., 2012 | |
| Mouse/ R6/1 | effects | ||||
| (reduced | |||||
| immobility) |
Abbreviations: AD, Alzheimer’s disease; CCI, controlled cortical impact; FASD, fetal alcohol spectrum disorder; FPI, fluid percussion injury; HD, Huntington’s disease; MCAO, middle cerebral artery occlusion; MWM, Morris Water Maze; PD, Parkinson’s disease; TBI, traumatic brain injury.